Indian Journal of Clinical Biochemistry

, Volume 33, Issue 2, pp 184–189 | Cite as

Polymorphic Variation in Double Strand Break Repair Gene in Indian Population: A Comparative Approach with Worldwide Ethnic Group Variations

  • Raju Kumar Mandal
  • Rama Devi Mittal
Original Article


DNA repair capacity is essential in maintaining cellular functions and homeostasis. Identification of genetic polymorphisms responsible for reduced DNA repair capacity may allow better cancer prevention. Double strand break repair pathway plays critical roles in maintaining genome stability. Present study was conducted to determine distribution of XRCC3 Exon 7 (C18067T, rs861539) and XRCC7 Intron 8 (G6721T, rs7003908) gene polymorphisms in North Indian population and compare with different populations globally. The genotype assays were performed in 224 normal healthy individuals of similar ethnicity using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Allelic frequencies of wild type were 79% (C) in XRCC3 Exon 7 C > T and 57% (G) in XRCC7 Intron 8 (G > T) 57% (G) observed. On the other hand, the variant allele frequency were 21% (T) in XRCC3 Exon 7 C > T and 43% (T) in XRCC7 Intron 8 G > T respectively. Major differences from other ethnic populations were observed. Our results suggest that frequency in these DNA repair genes exhibit distinctive pattern in India that could be attributed to ethnicity variation. This could assist in high-risk screening of humans exposed to environmental carcinogens and cancer predisposition in different ethnic groups.


DNA repair genes Polymorphism Ethnic group North India 


Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Wu X, Zhao H, Suk R, Christiani DC. Genetic susceptibility to tobacco-related cancer. Oncogene. 2004;23:6500–3.CrossRefPubMedGoogle Scholar
  2. 2.
    Lahtz C, Pfeifer GP. Epigenetic changes of DNA repair genes in cancer. J Mol Cell Biol. 2011;3:51–8.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Srivastava M, Raghavan SC. DNA double-strand break repair inhibitors as cancer therapeutics. Chem Biol. 2015;22:17–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Griffin CS. Aneuploidy, centrosome activity and chromosome instability in cells deficient in homologous recombination repair. Mutat Res. 2002;504:149–55.CrossRefPubMedGoogle Scholar
  5. 5.
    Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Lopez-Cima MF, Gonzalez-Arriaga P, Garcí-Castro L, Pascual T, Marron MG, Puente XS, Tardon A. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer. 2007;16:162–3.CrossRefGoogle Scholar
  7. 7.
    Wang SY, Peng L, Li CP, Li AP, Zhou JW, Zhang ZD, Liu QZ. Genetic variants of the XRCC7 gene involved in DNA repair and risk of human bladder cancer. Int J Urol. 2008;15:534–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomark Prev. 2002;11:1513–30.Google Scholar
  9. 9.
    Lindh AR, Rafii S, Schultz N, Cox A, Helleday T. Mitotic defects in XRCC3 variants T241 M and D213 N and their relation to cancer susceptibility. Hum Mol Genet. 2006;15:1217–24.CrossRefPubMedGoogle Scholar
  10. 10.
    Sturgis EM, Clayman GL, Guan Y, Guo Z, Wei Q. DNA repair in lymphoblastoid cell lines from patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 1999;125:185–90.CrossRefPubMedGoogle Scholar
  11. 11.
    Nasiri M, Saadat I, Omidvari S, Saadat M. Genetic variation in DNA repair gene XRCC7 (G6721T) and susceptibility to breast cancer. Gene. 2012;505:195–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Kittles RA, Weiss KM. Race, ancestry, and genes: implications for defining disease risk. Annu Rev Genomics Hum Genet. 2003;4:33–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst. 2000;92:874–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Matullo G, Guarrera S, Sacerdote C, Polidoro S, Davico L, Gamberini S, Karagas M, Casetta G, Rolle L, Piazza A, Vineis P. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomark Prev. 2005;14:2569–78.CrossRefGoogle Scholar
  15. 15.
    Kietthubthew S, Sriplung H, Au WW, Ishida T. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int J Hyg Environ Health. 2006;209:21–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Dhillon VS, Yeoh E, Fenech M. DNA repair gene polymorphisms and prostate cancer risk in South Australia—results of a pilot study. Urol Oncol. 2011;29:641–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Casson AG, Zheng Z, Evans SC, Veugelers PJ, Porter GA, Guernsey DL. Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis. 2005;26:1536–41.CrossRefPubMedGoogle Scholar
  18. 18.
    Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y. Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J Thorac Oncol. 2012;7:954–62.CrossRefPubMedGoogle Scholar
  19. 19.
    Misra RR, Ratnasinghe D, Tangrea JA, Virtamo J, Andersen MR, Barrett M, Taylor PR, Albanes D. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett. 2003;191:171–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, Bartsch H, Schmezer P. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis. 2004;25:2433–41.CrossRefPubMedGoogle Scholar
  21. 21.
    Fabiani E, D’Alò F, Scardocci A, Greco M, Di Ruscio A, Criscuolo M, Fianchi L, Pagano L, Hohaus S, Leone G, Voso MT. Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes. Leuk Res. 2009;33:1068–71.CrossRefPubMedGoogle Scholar
  22. 22.
    Sliwinski T, Walczak A, Przybylowska K, Rusin P, Pietruszewska W, Zielinska-Blizniewska H, Olszewski J, Morawiec-Sztandera A, Jendrzejczyk S, Mlynarski W, Majsterek I. Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population. Exp Mol Pathol. 2010;89:358–66.CrossRefPubMedGoogle Scholar
  23. 23.
    Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. 2011;73:138–46.CrossRefPubMedGoogle Scholar
  24. 24.
    Hirata H, Hinoda Y, Matsuyama H, Tanaka Y, Okayama N, Suehiro Y, Zhao H, Urakami S, Kawamoto K, Kawakami T, Igawa M, Naito K, Dahiya R. Polymorphisms of DNA repair genes are associated with renal cell carcinoma. Biochem Biophys Res Commun. 2006;342:1058–62.CrossRefPubMedGoogle Scholar
  25. 25.
    Wang LE, Bondy ML, Shen H, El-Zein R, Aldape K, Cao Y, Pudavalli V, Levin VA, Yung WK, Wei Q. Polymorphisms of DNA repair genes and risk of glioma. Cancer Res. 2004;64:5560–3.CrossRefPubMedGoogle Scholar

Copyright information

© Association of Clinical Biochemists of India 2017

Authors and Affiliations

  1. 1.Department of Urology and Renal TransplantationSanjay Gandhi Post Graduate Institute of Medical SciencesLucknowIndia

Personalised recommendations